These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38704758)

  • 21. A multi-targeted liquid chromatography-mass spectrometry screening procedure for the detection in human urine of drugs non-prohibited in sport commonly used by the athletes.
    Mazzarino M; Cesarei L; de la Torre X; Fiacco I; Robach P; Botrè F
    J Pharm Biomed Anal; 2016 Jan; 117():47-60. PubMed ID: 26342446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging drugs affecting skeletal muscle function and mitochondrial biogenesis - Potential implications for sports drug testing programs.
    Thevis M; Schänzer W
    Rapid Commun Mass Spectrom; 2016 Mar; 30(5):635-51. PubMed ID: 26842585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of cobalt for human sports drug testing purposes using ICP- and LC-ICP-MS.
    Knoop A; Planitz P; Wüst B; Thevis M
    Drug Test Anal; 2020 Nov; 12(11-12):1666-1672. PubMed ID: 33142033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Doping control analysis of metamfepramone and two major metabolites using liquid chromatography-tandem mass spectrometry.
    Thevis M; Sigmund G; Thomas A; Gougoulidis V; Rodchenkov G; Schänzer W
    Eur J Mass Spectrom (Chichester); 2009; 15(4):507-15. PubMed ID: 19661559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple incidence of the prescription diuretic hydrochlorothiazide in compounded nutritional supplements.
    Favretto D; Visentin S; Scrivano S; Roselli E; Mattiazzi F; Pertile R; Vogliardi S; Tucci M; Montisci M
    Drug Test Anal; 2019 Mar; 11(3):512-522. PubMed ID: 30194914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The forensic response after an adverse analytical finding (doping) involving a selective androgen receptor modulator (SARM) in human athlete.
    Kintz P
    J Pharm Biomed Anal; 2022 Jan; 207():114433. PubMed ID: 34715583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Doping control analysis of trimetazidine and characterization of major metabolites using mass spectrometric approaches.
    Sigmund G; Koch A; Orlovius AK; Guddat S; Thomas A; Schänzer W; Thevis M
    Drug Test Anal; 2014; 6(11-12):1197-205. PubMed ID: 24913825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of prohibited, small peptides in urine for sports drug testing by means of nano-liquid chromatography/benchtop quadrupole orbitrap tandem-mass spectrometry.
    Thomas A; Walpurgis K; Krug O; Schänzer W; Thevis M
    J Chromatogr A; 2012 Oct; 1259():251-7. PubMed ID: 22901302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expanding analytical options in sports drug testing: Mass spectrometric detection of prohibited substances in exhaled breath.
    Thevis M; Krug O; Geyer H; Schänzer W
    Rapid Commun Mass Spectrom; 2017 Aug; 31(15):1290-1296. PubMed ID: 28508503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Body fluid contamination in the context of an adverse analytical finding in doping: About a case involving ostarine.
    Alvarez JC; Etting I; Larabi IA
    Clin Chim Acta; 2024 Apr; 557():117871. PubMed ID: 38467244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro metabolism studies on the selective androgen receptor modulator (SARM) LG121071 and its implementation into human doping controls using liquid chromatography-mass spectrometry.
    Knoop A; Krug O; Vincenti M; Schänzer W; Thevis M
    Eur J Mass Spectrom (Chichester); 2015; 21(1):27-36. PubMed ID: 25906032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sports drug testing and the athletes' exposome.
    Thevis M; Kuuranne T; Fedoruk M; Geyer H
    Drug Test Anal; 2021 Nov; 13(11-12):1814-1821. PubMed ID: 34694748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of new exemestane metabolites by liquid chromatography interfaced to electrospray-tandem mass spectrometry.
    de Albuquerque Cavalcanti G; Carius Garrido B; Dias Leal F; Costa Padilha M; Mazzarino M; de la Torre X; Botre F; Radler de Aquino Neto F
    J Steroid Biochem Mol Biol; 2011 Nov; 127(3-5):248-54. PubMed ID: 21924357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mass spectrometric characterization of a prolyl hydroxylase inhibitor GSK1278863, its bishydroxylated metabolite, and its implementation into routine doping controls.
    Thevis M; Milosovich S; Licea-Perez H; Knecht D; Cavalier T; Schänzer W
    Drug Test Anal; 2016 Aug; 8(8):858-63. PubMed ID: 26361079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Annual banned-substance review: Analytical approaches in human sports drug testing 2020/2021.
    Thevis M; Kuuranne T; Geyer H
    Drug Test Anal; 2022 Jan; 14(1):7-30. PubMed ID: 34788500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monitoring phosphodiesterase-4 inhibitors using liquid chromatography/(tandem) mass spectrometry in sports drug testing.
    Thevis M; Krug O; Schänzer W
    Rapid Commun Mass Spectrom; 2013 May; 27(9):993-1004. PubMed ID: 23592202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of Stimulants and Narcotics by Liquid Chromatography-Tandem Mass Spectrometry and Gas Chromatography-Mass Spectrometry for Sports Doping Control.
    Ahrens BD; Kucherova Y; Butch AW
    Methods Mol Biol; 2016; 1383():247-63. PubMed ID: 26660193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mildronate (Meldonium) in professional sports - monitoring doping control urine samples using hydrophilic interaction liquid chromatography - high resolution/high accuracy mass spectrometry.
    Görgens C; Guddat S; Dib J; Geyer H; Schänzer W; Thevis M
    Drug Test Anal; 2015; 7(11-12):973-9. PubMed ID: 25847280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reply to the paper of Breuer et al.: complementary information concerning the suspected interindividual transmission of GW1516, a substance prohibited in sport, through intimate contact-a case report.
    Kintz P
    Forensic Toxicol; 2024 Jun; ():. PubMed ID: 38935295
    [No Abstract]   [Full Text] [Related]  

  • 40. Doping control analysis of methoxyphenamine using liquid chromatography-tandem mass spectrometry.
    Thevis M; Sigmund G; Koch A; Guddat S; Maurer HH; Schänzer W
    Eur J Mass Spectrom (Chichester); 2008; 14(3):145-52. PubMed ID: 18708694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.